We are thrilled to announce the resounding success of the AHEA Summit 2024, held in conjunction with JPM2024. This event has marked a significant milestone in our journey towards healthcare innovation and global collaboration.
Networking Session: Cultivating Connections
The summit began with a networking session, providing a platform for industry professionals to connect and exchange ideas in a vibrant environment. The experience was enhanced with a complimentary selection of gourmet cuisine.
Opening Remarks: Visionary Leadership
After the networking session, Lei Wang, the Executive Vice President & International and China President of AstraZeneca, and Yisu Jin, the Founder of SVLC, AHEA, and IntelliPro Group, graced the stage for the opening remarks. Lei Wang, renowned for her strategic leadership in the pharmaceutical industry, and Yisu Jin, celebrated for his entrepreneurial acumen and recognition in the 2023 Forbes 100 Most Influential Chinese list, established an insightful tone for the summit's discussions.
Lei Wang emphasized the summit's goal, stating, "The establishment of AHEA aims to provide a platform for global healthcare leaders to come together and discuss global healthcare trends. This platform is designed to facilitate discussions that can help drive global transactions and create more possibilities to address unmet clinical needs."
Panel Discussions: In-Depth Industry Analysis
Panel 1: Value Creation By Global Partnership
Next, the first panel discussion focused on "Value Creation By Global Partnership," featuring:
The panelists explored case studies of successful collaborations, strategies for overcoming cross-border challenges, and the role of technology in facilitating international alliances. This session underscored the significance of diverse perspectives and expertise in advancing healthcare outcomes on a global scale.
Panel 2: Navigating Investment Opportunities in 2024
Following the first panel, the second panel discussion, "Navigating Investment Opportunities in 2024," included:
The panelists convened to provide valuable insights into the evolving trends landscape within the healthcare sector.
AHEA’s Mission: Promoting Collaborative Innovation
Our mission at AHEA is clear and forward-thinking: to catalyze and nurture successful partnerships by harnessing disruptive technology and innovative platforms. This strategic approach is designed to significantly influence and reshape the healthcare landscape. Our ambition is to establish ourselves as the go-to advisors for the next generation of industry trailblazers.
In line with our vision, we see AHEA as a pivotal connector and facilitator in the realm of scientific and business collaborations. We are committed to being the bridge that links different sectors, fostering scientific collaboration, and crafting robust business partnerships. This dedication positions us not just as participants but as key drivers in enhancing global healthcare collaboration, thereby contributing profoundly to the advancement of the healthcare industry worldwide.
As we reflect on the success of the AHEA Summit 2024, we look forward with renewed vigor to our continued role in shaping the future of healthcare. Our commitment to innovation, collaboration, and leadership in the healthcare industry remains unwavering.
On January 11, 2026, during J.P. Morgan Healthcare Week, the American Healthcare Executive Association (AHEA) convened senior leaders from across global biopharma in San Francisco for the 2026 Global Biopharma Leadership Forum — creating a trusted platform for strategic exchange ahead of the industry’s most influential gathering of the year.
On January 11, 2026, during J.P. Morgan Healthcare Week, American Healthcare Executive Association was proud to partner with bioSeedin to co-host the BIOseedin Winter Innovation Partnering Summit in San Francisco.
On June 15, 2025, AHEA was proud to co-host the Global Biopharma Leadership Forum at Harvard Medical School, alongside IntelliPro, BayHelix Group, CSSA@HMS, and MSQ Ventures, with generous support from BioCentury and UHY.
On June 14, 2025, during the BIO International Convention, AHEA was honored to co-host the Executive Workshop at PwC Boston Headquarters, in partnership with PwC, IntelliPro, BayHelix, and MSQ Ventures.
It was a pleasure to co-host the “NewCo & Out-Licensing” forum with Jones Day and IntelliPro bringing together leaders from biotech, pharma, and investment to explore cross-border collaboration and global expansion strategies.
We are thrilled to announce the resounding success of the AHEA Summit 2024, held in conjunction with JPM2024. This event has marked a significant milestone in our journey towards healthcare innovation and global collaboration.
contact@ahea.io